7-[2-Amino(phenyl)acetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (CED0100087)

Record Information
Version1.0
Creation Date2026-03-26 18:32:52 UTC
Update Date2026-05-20 19:23:40 UTC
SynCED IDCED0100087
Secondary Accession Numbers
  • CHEM055857
Identification
Common Name7-[2-Amino(phenyl)acetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid
ClassSmall Molecule
Description
7-[2-Amino(phenyl)acetamido]-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid belongs to the beta lactams, a subclass of lactams within the organic compounds. This organoheterocyclic compound has the formula C16H17N3O4S1 and an average molecular weight of 347.39 g/mol. It is found in or released from one recorded source: healthcare, pharmaceuticals & veterinary products, specifically antibiotics. Recorded exposure routes for this substance include oral and inhalation.
Contaminant TypeNot Available
Chemical Structure
SynonymsNot Available
Chemical FormulaC16H17N3O4S1
Average Molecular Mass347.390 g/mol
Monoisotopic Mass347.094 g/mol
CAS Registry Number108260-04-4
IUPAC NameNot Available
Traditional NameNot Available
SMILESCC1=C(N2C(SC1)C(NC(=O)C(N)C1=CC=CC=C1)C2=O)C(O)=O
InChI IdentifierInChI=1S/C16H17N3O4S/c1-8-7-24-15-11(14(21)19(15)12(8)16(22)23)18-13(20)10(17)9-5-3-2-4-6-9/h2-6,10-11,15H,7,17H2,1H3,(H,18,20)(H,22,23)
InChI KeyZAIPMKNFIOOWCQ-UHFFFAOYSA-N
Chemical Taxonomy
ClassificationNot classified
Biological Properties
StatusDetected and Not Quantified
OriginNot Available
Cellular LocationsNot Available
Biofluid LocationsNot Available
Tissue LocationsNot Available
ApplicationsNot Available
Biological RolesNot Available
Chemical RolesNot Available
Organoleptic EffectsNot Available
Physical Properties
StateNot Available
AppearanceNot Available
Experimental Properties
PropertyValue
Melting PointNot Available
Boiling PointNot Available
SolubilityNot Available
Predicted PropertiesNot Available
Spectra
SpectraNot Available
Toxicity Profile
Toxicity Values
Toxicity ValueOrganismDose DescriptorRoute of ExposurePredicted or ExperimentalToxicity RatingReference
6560.0 Log mg/kg [3700:12000]RatLD50oralpredictedNot AvailableNot Available
Toxicity / Toxin ClassNot Available
Mechanism of ToxicityNot Available
Carcinogenicity (IARC Classification)Not Available
Minimum Risk LevelNot Available
SymptomsNot Available
TreatmentNot Available
Health Effects
Health EffectRelationshipDirectionReference
Exposure Sources
Source IDSourceSectorReference
CEDs000306Antibiotics?Antibiotics are synthetic or semi-synthetic compounds used to treat bacterial infections in humans and animals.Healthcare, pharmaceuticals & veterinary productsNot Available
CEDs000696Nanotechnology?Nanotechnology involves the manipulation of materials at the molecular or atomic level, typically within the range of 1 to 100 nanometers.Industrial manufacturing & chemical processingNot Available
Pathways
0 pathwaysPathway Source: PathBank

No pathways found

No metabolic pathways have been associated with this synthetic chemical

Targets
StructureProteinUniProt IDOrganismRelationshipDetails
Baculoviral IAP repeat-containing protein 2 structureClick to view 3D structureBaculoviral IAP repeat-containing protein 2Q13490HumansPredicted (SEA)
Prediction Confidence Score
0.257
Applicability Domain
0.275 Low confidence
Statistical Significance
0.0039
Supporting Reference Compounds
19
E-value
30.5947
Apoptotic protease-activating factor 1 structureClick to view 3D structureApoptotic protease-activating factor 1O14727HumansPredicted (SEA)
Prediction Confidence Score
0.252
Applicability Domain
0.337
Statistical Significance
0.0163
Supporting Reference Compounds
112
E-value
126.661
Click to view 3D structureNeprilysinP07861Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.252
Applicability Domain
0.28 Low confidence
Statistical Significance
0.0349
Supporting Reference Compounds
38
E-value
272.005
E3 ubiquitin-protein ligase XIAP structureClick to view 3D structureE3 ubiquitin-protein ligase XIAPP98170HumansPredicted (SEA)
Prediction Confidence Score
0.251
Applicability Domain
0.275 Low confidence
Statistical Significance
0.0107
Supporting Reference Compounds
36
E-value
83.0651
Histone deacetylase 4 structureClick to view 3D structureHistone deacetylase 4P56524HumansPredicted (SEA)
Prediction Confidence Score
0.248
Applicability Domain
0.273 Low confidence
Statistical Significance
0.1197
Supporting Reference Compounds
185
E-value
931.544
Neurogenic locus notch homolog protein 2 structureClick to view 3D structureNeurogenic locus notch homolog protein 2Q04721HumansPredicted (SEA)
Prediction Confidence Score
0.244
Applicability Domain
0.244 Low confidence
Statistical Significance
0.0013
Supporting Reference Compounds
1
E-value
9.9647
Neurogenic locus notch homolog protein 4 structureClick to view 3D structureNeurogenic locus notch homolog protein 4Q99466HumansPredicted (SEA)
Prediction Confidence Score
0.244
Applicability Domain
0.244 Low confidence
Statistical Significance
0.0013
Supporting Reference Compounds
1
E-value
9.9647
Click to view 3D structureProcathepsin LP07154Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.244
Applicability Domain
0.286 Low confidence
Statistical Significance
0.0094
Supporting Reference Compounds
10
E-value
73.4118
Cathepsin S structureClick to view 3D structureCathepsin SP25774HumansPredicted (SEA)
Prediction Confidence Score
0.243
Applicability Domain
0.253 Low confidence
Statistical Significance
0.0817
Supporting Reference Compounds
141
E-value
636.262
Cytochrome P450 2D6 structureClick to view 3D structureCytochrome P450 2D6P10635HumansPredicted (SEA)
Prediction Confidence Score
0.242
Applicability Domain
0.253 Low confidence
Statistical Significance
0.5572
Supporting Reference Compounds
1130
E-value
4338.15
Kappa-type opioid receptor structureClick to view 3D structureKappa-type opioid receptorP41145HumansPredicted (SEA)
Prediction Confidence Score
0.242
Applicability Domain
0.253 Low confidence
Statistical Significance
0.2762
Supporting Reference Compounds
532
E-value
2150.04
Click to view 3D structureSolute carrier family 22 member 6Q4U2R8HumansPredicted (SEA)
Prediction Confidence Score
0.491
Applicability Domain
0.846
Statistical Significance
1.00e-05
Supporting Reference Compounds
26
E-value
0.0778492
Click to view 3D structureOrganic anion transporter 3Q8TCC7HumansPredicted (SEA)
Prediction Confidence Score
0.491
Applicability Domain
0.846
Statistical Significance
1.00e-05
Supporting Reference Compounds
20
E-value
0.0778492
Click to view 3D structureStreptokinase AP10520Streptococcus pyogenes serotype M1Predicted (SEA)
Prediction Confidence Score
0.446
Applicability Domain
0.774
Statistical Significance
7.60e-04
Supporting Reference Compounds
425
E-value
5.91654
Speckle-type POZ protein structureClick to view 3D structureSpeckle-type POZ proteinO43791HumansPredicted (SEA)
Prediction Confidence Score
0.395
Applicability Domain
0.395
Statistical Significance
3.00e-05
Supporting Reference Compounds
1
E-value
0.233548
Carboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1 structureClick to view 3D structureCarboxy-terminal domain RNA polymerase II polypeptide A small phosphatase 1Q9GZU7HumansPredicted (SEA)
Prediction Confidence Score
0.386
Applicability Domain
0.774
Statistical Significance
4.10e-04
Supporting Reference Compounds
128
E-value
3.19182
Solute carrier family 22 member 11 structureClick to view 3D structureSolute carrier family 22 member 11Q9NSA0HumansPredicted (SEA)
Prediction Confidence Score
0.384
Applicability Domain
0.486
Statistical Significance
4.00e-05
Supporting Reference Compounds
9
E-value
0.311397
Solute carrier family 15 member 2 structureClick to view 3D structureSolute carrier family 15 member 2Q63424Rattus norvegicusPredicted (SEA)
Prediction Confidence Score
0.364
Applicability Domain
0.846
Statistical Significance
1.00e-05
Supporting Reference Compounds
6
E-value
0.0778492
Solute carrier family 15 member 2 structureClick to view 3D structureSolute carrier family 15 member 2Q16348HumansPredicted (SEA)
Prediction Confidence Score
0.33
Applicability Domain
0.846
Statistical Significance
9.10e-04
Supporting Reference Compounds
6
E-value
7.08428
Tyrosine-protein phosphatase non-receptor type 11 structureClick to view 3D structureTyrosine-protein phosphatase non-receptor type 11Q06124HumansPredicted (SEA)
Prediction Confidence Score
0.286
Applicability Domain
0.469
Statistical Significance
0.008
Supporting Reference Compounds
109
E-value
62.4351
72 kDa type IV collagenase structureClick to view 3D structure72 kDa type IV collagenaseP08253HumansPredicted (SEA)
Prediction Confidence Score
0.268
Applicability Domain
0.333
Statistical Significance
0.0934
Supporting Reference Compounds
400
E-value
726.956
DNA (cytosine-5)-methyltransferase 1 structureClick to view 3D structureDNA (cytosine-5)-methyltransferase 1P26358HumansPredicted (SEA)
Prediction Confidence Score
0.265
Applicability Domain
0.417
Statistical Significance
0.0192
Supporting Reference Compounds
116
E-value
149.626
Click to view 3D structureBeta-lactamaseB2ZTR6Acinetobacter baumanniiPredicted (SEA)
Prediction Confidence Score
0.264
Applicability Domain
0.349
Statistical Significance
8.00e-05
Supporting Reference Compounds
3
E-value
0.622794
Click to view 3D structureADC-11D6NSM8Acinetobacter baumanniiPredicted (SEA)
Prediction Confidence Score
0.264
Applicability Domain
0.349
Statistical Significance
8.00e-05
Supporting Reference Compounds
3
E-value
0.622794
Baculoviral IAP repeat-containing protein 8 structureClick to view 3D structureBaculoviral IAP repeat-containing protein 8Q96P09HumansPredicted (SEA)
Prediction Confidence Score
0.261
Applicability Domain
0.275 Low confidence
Statistical Significance
0.0019
Supporting Reference Compounds
4
E-value
14.5578
Concentrations
Not Available
External Links
IdentifiersNot Available
References
Synthesis ReferenceNot Available
MSDSNot Available
General ReferencesNot Available